NCT03220165View on ClinicalTrials.gov

Radiolabeled Study to Determine the Mass Balance of [14C] MGL-3196

PHASE1CompletedINTERVENTIONAL
Enrollment

8

Participants

Timeline

Start Date

August 6, 2017

Primary Completion Date

September 3, 2017

Study Completion Date

September 3, 2017

Conditions
Healthy
Interventions
DRUG

MGL-3196

oral, 100 mg

Trial Locations (1)

78217

Worldwide Clinical Trials Early Phase Services, LLC, San Antonio

Sponsors

Collaborators (1)

Worldwide Clinical Trials
All Listed Sponsors
collaborator

Worldwide Clinical Trials

OTHER

lead

Madrigal Pharmaceuticals, Inc.

INDUSTRY